During the past decade, Dickstein Cancer Treatment Center conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 24 clinical trials were completed, i.e. on average, 58.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 18 clinical trials were completed. i.e. 360% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dickstein Cancer Treatment Center" #1 sponsor was "National Cancer Institute (NCI)" with 35 trials, followed by "NRG Oncology" with 7 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dickstein Cancer Treatment Center" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "American College of Radiology Imaging Network" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Dickstein Cancer Treatment Center" are "Invasive Breast Carcinoma" (5 trials), "Recurrent Breast Carcinoma" (5 trials), "Recurrent Ovarian Carcinoma" (5 trials), "Ovarian Seromucinous Carcinoma" (4 trials) and "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials). Many other conditions were trialed in "Dickstein Cancer Treatment Center" in a lesser frequency.

Most popular intervention types in "Dickstein Cancer Treatment Center" are "Drug" (47 trials), "Other" (36 trials), "Biological" (23 trials), "Procedure" (16 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (18 trials), "Quality-of-Life Assessment" (14 trials), "Computed Tomography" (10 trials), "Paclitaxel" (10 trials) and "Questionnaire Administration" (10 trials). Other intervention names were less common.

The vast majority of trials in "Dickstein Cancer Treatment Center" are 38 trials for "All" genders, 17 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Dickstein Cancer Treatment Center". undefined are not yet recruiting, 12 are recruiting, 38 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Dickstein Cancer Treatment Center, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Dickstein Cancer Treatment Center, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".